Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.
about
Pneumococcal Capsules and Their Types: Past, Present, and FutureHuman ficolin-2 recognition versatility extended: an update on the binding of ficolin-2 to sulfated/phosphated carbohydratesPhenotypic and molecular study of pneumococci causing respiratory tract infections. A 3-year prospective cohort.Commercially available complement component-depleted sera are unexpectedly codepleted of ficolin-2.Identification of Streptococcus pneumoniae serotype 11E, serovariant 11Av and mixed populations by high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and flow cytometric serotyping assay (FCSA)Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro.Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °C.Discovery of Novel Pneumococcal Serotype 35D, a Natural WciG-Deficient Variant of Serotype 35B.Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.A novel genetic variant of Streptococcus pneumoniae serotype 11A discovered in Fiji.The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.WciG O-Acetyltransferase Functionality Differentiates Pneumococcal Serotypes 35C and 42.Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine.
P2860
Q27006887-C26FF591-1EE5-4E82-9345-946E3C648BB7Q27696251-A6F08439-0847-4017-AF18-0736C2BA0CB6Q33735215-A3506275-145C-49C9-A8D2-3D49230B6B88Q34260811-8FF0CF72-E66D-4BC5-A603-EDB7091A2A98Q35195497-73D26419-C15A-45E7-8B76-758D81DC676FQ35619025-BAF3F26A-4835-414B-A34A-52B0437C6ED3Q36029667-EAD36992-53AD-4B3C-8525-84F572949B51Q37163698-DC65FC00-CA51-496D-A4A0-9D9AA82F40ECQ38377085-8575D4A6-F6CA-41EE-853E-48F87A5D82EEQ38757002-0E511186-C416-4A0C-BFEA-EAEE2EC02A2DQ39164566-DFD39572-DAAA-4C13-9D37-645351DF68EEQ40123264-716871C8-A547-4D4F-BE44-DF522CA2C64DQ46346495-5A945F98-0F66-47D6-902B-B42695DE1AB0Q48207606-E419656A-B498-40C7-B34C-747CB8FA20E0Q49215526-AEDBD221-8915-423F-9CC9-950DE6885568Q55399661-419B45AC-37DE-4C0B-83E6-4B2BDEC44754
P2860
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low invasiveness of pneumococc ...... complement pathway activation.
@ast
Low invasiveness of pneumococc ...... complement pathway activation.
@en
Low invasiveness of pneumococc ...... complement pathway activation.
@nl
type
label
Low invasiveness of pneumococc ...... complement pathway activation.
@ast
Low invasiveness of pneumococc ...... complement pathway activation.
@en
Low invasiveness of pneumococc ...... complement pathway activation.
@nl
prefLabel
Low invasiveness of pneumococc ...... complement pathway activation.
@ast
Low invasiveness of pneumococc ...... complement pathway activation.
@en
Low invasiveness of pneumococc ...... complement pathway activation.
@nl
P2093
P2860
P356
P1476
Low invasiveness of pneumococc ...... complement pathway activation
@en
P2093
Allison M Brady
Gary R Cutter
Juan J Calix
P2860
P304
P356
10.1093/INFDIS/JIU195
P407
P577
2014-03-27T00:00:00Z